Related Experiment Video
Updated: Aug 9, 2025

13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.3K
Triheptanoin, an odd-medium-chain triglyceride, impacts brain cognitive function in young and aged mice
L S da Rocha1, C B Mendes1, J S Silva1
1Institute of Biological and Health Science, Federal University of Alagoas, Maceió, Brazil.
Nutritional Neuroscience
|February 22, 2023
Summary
A ketogenic diet impaired memory in aged mice, but supplementing it with triheptanoin prevented this decline. Triheptanoin may enhance brain bioenergetics and cognitive function.
Area of Science:
- Neuroscience
- Metabolic research
- Aging research
Background:
- Brain aging impairs cognitive functions like memory due to reduced glucose metabolism.
- Anaplerotic substrates can enhance mitochondrial ATP generation and are explored for neurological treatments.
Purpose of the Study:
- To investigate if improving oxidative capacity via diet ameliorates cognitive decline in adult and aged mice.
- To assess the effects of a ketogenic diet and triheptanoin supplementation on cognitive function and brain bioenergetics.
Main Methods:
- Adult and aged mice were fed a control diet, ketogenic diet (KD), or KD with triheptanoin for 12 weeks.
- Cognitive function was assessed using Y-maze and novel object recognition tests.
- Acetylcholinesterase activity and glucose transporter 3 (GLUT3) expression were analyzed.
Main Results:
- The ketogenic diet alone reduced spontaneous alternation in aged mice and lowered acetylcholinesterase activity and GLUT3 expression in specific brain regions.
- Triheptanoin supplementation to the ketogenic diet prevented memory impairment in aged mice.
- Triheptanoin maintained acetylcholinesterase activity and GLUT3 expression levels comparable to controls.
Conclusions:
- Ketogenic diet alone may negatively impact cognitive function in aged brains.
- Triheptanoin supplementation shows potential in preserving cognitive function by supporting brain bioenergetic capacity.
- Triheptanoin may be a promising therapeutic agent for age-related cognitive decline.

